Investor Alert

New York Markets Close in:

press release

Nov. 29, 2021, 7:00 a.m. EST

Apellis Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference

WALTHAM, Mass., Nov 29, 2021 (GLOBE NEWSWIRE via COMTEX) -- WALTHAM, Mass., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals , Inc. /zigman2/quotes/202103251/composite APLS -0.97% , a global biopharmaceutical company and leader in complement, today announced that the company will present at the 4th Annual Evercore ISI HealthCONx Conference on Thursday, December 2, 2021 at 8:00 a.m. ET. The conference will be held in a virtual meeting format.

The conference event will be available via a live webcast from the "Events and Presentations" page of the "Investors and Media" section of the company's website . A replay of the webcast will be available for 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, we aim to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology. For more information, please visit www.apellis.com .

Investor Contact:
Meredith Kaya


Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

(C) Copyright 2021 GlobeNewswire, Inc. All rights reserved.

US : U.S.: Nasdaq
$ 41.75
-0.41 -0.97%
Volume: 44,204
May 18, 2022 9:52a
P/E Ratio
Dividend Yield
Market Cap
$4.49 billion
Rev. per Employee

Partner Center

Link to MarketWatch's Slice.